Total Payments
$192,352
2024 Payments
$24,550
Companies
75
Transactions
1,754
Medicare Patients
6,692
Medicare Billing
$813,783
Payment Breakdown by Category
Other$152,925 (79.5%)
Food & Beverage$28,150 (14.6%)
Travel$6,879 (3.6%)
Consulting$4,300 (2.2%)
Education$98.51 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $152,925 | 80 | 79.5% |
| Food and Beverage | $28,150 | 1,613 | 14.6% |
| Travel and Lodging | $6,879 | 27 | 3.6% |
| Consulting Fee | $4,300 | 3 | 2.2% |
| Education | $98.51 | 31 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $106,566 | 203 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $34,255 | 121 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $17,685 | 109 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $6,925 | 60 | $0 (2021) |
| SK Life Science, Inc. | $4,075 | 46 | $0 (2024) |
| Allergan, Inc. | $3,520 | 58 | $0 (2022) |
| UCB, Inc. | $2,199 | 118 | $0 (2024) |
| Biogen, Inc. | $1,347 | 92 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,190 | 80 | $0 (2022) |
| Amgen Inc. | $1,174 | 77 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24,550 | 232 | ABBVIE INC. ($20,738) |
| 2023 | $27,275 | 275 | AbbVie Inc. ($23,643) |
| 2022 | $50,477 | 266 | ABBVIE INC. ($39,225) |
| 2021 | $34,458 | 269 | AbbVie Inc. ($22,917) |
| 2020 | $7,782 | 160 | Teva Pharmaceuticals USA, Inc. ($5,201) |
| 2019 | $12,025 | 208 | Teva Pharmaceuticals USA, Inc. ($9,036) |
| 2018 | $11,260 | 183 | Teva Pharmaceuticals USA, Inc. ($8,779) |
| 2017 | $24,525 | 161 | Supernus Pharmaceuticals, Inc. ($16,655) |
All Payment Transactions
1,754 individual payment records from CMS Open Payments — Page 1 of 71
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Neuroscience | ||||||
| 12/17/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: NEUROLOGY | ||||||
| 12/17/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Central Nervous System | ||||||
| 12/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/09/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Neurology | ||||||
| 12/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.27 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: EPILEPSY | ||||||
| 12/04/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $42.36 | General |
| Category: Narcoplepsy | ||||||
| 12/02/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $19.95 | General |
| 12/02/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Neurology | ||||||
| 12/01/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: PAIN | ||||||
| 11/25/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Neurology | ||||||
| 11/25/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $1.65 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Central Nervous System | ||||||
| 11/20/2024 | Lilly USA, LLC | EMGALITY (Drug), AMYVID, KISUNLA | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Neuroscience | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: PAIN | ||||||
| 11/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: PAIN | ||||||
| 11/13/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Insomnia | ||||||
| 11/12/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,384 | 5,606 | $517,546 | $174,233 |
| 2022 | 21 | 1,637 | 2,909 | $581,151 | $208,826 |
| 2021 | 19 | 1,795 | 3,090 | $607,258 | $227,793 |
| 2020 | 24 | 1,876 | 2,942 | $572,602 | $202,932 |
Total Patients
6,692
Total Services
14,547
Medicare Billing
$813,783
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 377 | 596 | $98,794 | $50,121 | 50.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 39 | 41 | $56,498 | $18,742 | 33.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 120 | 243 | $42,525 | $17,728 | 41.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 156 | 156 | $38,220 | $17,708 | 46.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 209 | 237 | $28,355 | $14,767 | 52.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 48 | 48 | $33,120 | $13,551 | 40.9% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 55 | 55 | $104,940 | $9,017 | 8.6% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 69 | 69 | $29,118 | $8,634 | 29.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 45 | 46 | $13,892 | $5,917 | 42.6% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 44 | 44 | $14,124 | $4,458 | 31.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 11 | 11 | $7,280 | $3,698 | 50.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 32 | $5,664 | $2,777 | 49.0% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 36 | 38 | $15,770 | $2,683 | 17.0% |
| 70450 | Ct scan head or brain without contrast | Office | 2023 | 26 | 26 | $9,551 | $1,297 | 13.6% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 14 | 14 | $12,040 | $1,212 | 10.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 23 | $1,735 | $941.91 | 54.3% |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | Office | 2023 | 35 | 3,650 | $3,650 | $393.59 | 10.8% |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | Office | 2023 | 25 | 250 | $2,000 | $360.41 | 18.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 27 | 27 | $270.00 | $226.80 | 84.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 406 | 647 | $102,873 | $56,416 | 54.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 207 | 207 | $50,715 | $24,099 | 47.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 143 | 291 | $50,925 | $22,630 | 44.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 77 | 78 | $53,820 | $22,610 | 42.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 257 | 296 | $31,672 | $18,070 | 57.1% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 32 | 32 | $44,096 | $13,937 | 31.6% |
About Dr. Dharmen Shah, M.D
Dr. Dharmen Shah, M.D is a Neurology healthcare provider based in Statesville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235225681.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dharmen Shah, M.D has received a total of $192,352 in payments from pharmaceutical and medical device companies, with $24,550 received in 2024. These payments were reported across 1,754 transactions from 75 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($152,925).
As a Medicare-enrolled provider, Shah has provided services to 6,692 Medicare beneficiaries, totaling 14,547 services with total Medicare billing of $813,783. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Statesville, NC
- Active Since 10/05/2006
- Last Updated 08/15/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1235225681
Products in Payments
- UBRELVY (Drug) $64,750
- QULIPTA (Drug) $44,591
- AJOVY (Biological) $16,346
- AJOVY (Drug) $14,084
- TROKENDI XR (Drug) $13,615
- ONZETRA Xsail (Drug) $6,731
- OXTELLAR XR (Drug) $4,015
- XCOPRI (Drug) $3,272
- APTIOM (Drug) $1,278
- Aimovig (Biological) $1,109
- Briviact (Drug) $914.49
- Neupro (Drug) $891.02
- VALTOCO (Drug) $834.37
- NUPLAZID (Drug) $830.36
- Fycompa (Drug) $744.06
- NURTEC ODT (Drug) $684.57
- EMGALITY (Drug) $650.18
- BOTOX (Biological) $600.35
- AUBAGIO (Drug) $577.34
- INGREZZA (Drug) $530.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.